SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma’s arm to acquire balance 25% outstanding shares in Sun Pharma de Mexico

29 Sep 2023 Evaluate

Sun Pharmaceutical Industries’ wholly-owned Subsidiary -- Sun Pharma (Netherlands) B.V. has signed a binding letter of intent to acquire the balance 25% outstanding shares of Sun Pharma de Mexico, S.A. de C.V., a subsidiary of the Company, where the Company is currently holding 75% shares.

Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de Mexico, S.A. de C.V. becoming a wholly-owned subsidiary of the Company.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1675.20 -17.95 (-1.06%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×